☆ 4.7 Article

Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Resection

ANNALS OF SURGICAL ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Surgery

Osteosarcopenia predicts poor prognosis for patients with intrahepatic cholangiocarcinoma after hepatic resection

Tomohiko Taniai et al.

Summary: This study aimed to evaluate the prognostic significance of osteosarcopenia in patients with intrahepatic cholangiocarcinoma (IHCC). The results showed that osteosarcopenia was associated with disease-free and overall survival, and it may serve as a predictor of adverse prognosis for patients undergoing hepatic resection for IHCC.

SURGERY TODAY (2023)

Add to Collection

Article Gastroenterology & Hepatology

The significance of osteosarcopenia as a predictor of the long-term outcomes in hepatocellular carcinoma after hepatic resection

Mitsuru Yanagaki et al.

Summary: Preoperative osteosarcopenia may be a prognostic factor in patients with hepatocellular carcinoma after hepatic resection. Our results suggest that the preoperative maintenance of skeletal muscle and bone density may potentially improve prognosis in hepatocellular carcinoma patients.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2023)

Add to Collection

Article Gastroenterology & Hepatology

Prognostic impact of osteosarcopenia in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel

Tsuyoshi Takeda et al.

Summary: This study aimed to evaluate the prognostic impact of osteosarcopenia in metastatic pancreatic cancer patients. The study found that patients with osteosarcopenia had poorer treatment response, shorter progression-free survival, and overall survival. Osteosarcopenia was also identified as an independent factor predicting shorter survival in metastatic pancreatic cancer patients.

PANCREATOLOGY (2023)

Add to Collection

Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Add to Collection

Article Surgery

Supervised Exercise Therapy and Adjuvant Chemotherapy for Pancreatic Cancer: A Prospective, Single-Arm, Phase II Open-Label, Nonrandomized, Historically Controlled Study

Ken-ichi Okada et al.

Summary: This study showed that supervised exercise therapy combined with adjuvant chemotherapy can improve the completion rate of S-1 adjuvant chemotherapy for pancreatic ductal adenocarcinoma patients, reduce frailty, and maintain good safety profile.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2022)

Add to Collection

Article Oncology

Impact of osteopenia on surgical and oncological outcomes in patients with pancreatic cancer

Kyohei Abe et al.

Summary: This study found that both sarcopenia and osteopenia have a significant impact on overall survival and disease-free survival in patients with pancreatic cancer after surgery. Sarcopenia was identified as an independent predictor of 1-year disease-free survival, while both sarcopenia and osteopenia were significant independent predictors of 2-year overall survival.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Osteosarcopenia is a potential predictor for the prognosis of patients who underwent hepatic resection for colorectal liver metastases

Kenei Furukawa et al.

Summary: Osteosarcopenia is commonly seen in patients undergoing liver resection for colorectal liver metastases and is significantly associated with overall survival. Female patients and those with lower body mass index are more likely to have osteosarcopenia.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2021)

Add to Collection

Article Endocrinology & Metabolism

Effects of High-Intensity Resistance Training on Osteopenia and Sarcopenia Parameters in Older Men with Osteosarcopenia-One-Year Results of the Randomized Controlled Franconian Osteopenia and Sarcopenia Trial (FrOST)

Wolfgang Kemmler et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2020)

Add to Collection

Editorial Material Geriatrics & Gerontology

Osteosarcopenia: epidemiology, diagnosis, and treatment-facts and numbers

Ben Kirk et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)

Add to Collection

Article Medicine, Research & Experimental

Impact of Osteopenia on Oncologic Outcomes After Curative Resection for Pancreatic Cancer

Takashi Motomura et al.

IN VIVO (2020)

Add to Collection

Article Oncology

Prognostic Value of Preoperative Nutritional and Immunological Factors in Patients with Pancreatic Ductal Adenocarcinoma

Toshiya Abe et al.

ANNALS OF SURGICAL ONCOLOGY (2018)

Add to Collection

Article Oncology

Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer

Shinya Okumura et al.

ANNALS OF SURGICAL ONCOLOGY (2017)

Add to Collection

Article Surgery

Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer

Shinya Okumura et al.

SURGERY (2015)

Add to Collection

Article Gastroenterology & Hepatology

Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma

Peter Peng et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2012)

Add to Collection

Review Surgery

The Clavien-Dindo Classification of Surgical Complications Five-Year Experience

Pierre A. Clavien et al.

ANNALS OF SURGERY (2009)

Add to Collection

Article Gastroenterology & Hepatology

Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer

Donald C. McMillan et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.